Create Medicines
Likely to Engage tag.Highly Engaged Employees

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

300 Technology Sq Ste 203, Cambridge, Ma...

Revenue

$9.7 Million

Industry

Business Services Research & Development

About Create Medicines

CREATE Medicines is a clinical-stage biotechnology company developing in vivo immune programming therapies using its proprietary mRNA-LNP platform. The company focuses on engineering immune cells directly inside the body, including T cells, NK cells, and myeloid cells, to create scalable, repeat-dose, off-the-shelf immunotherapies. Its pipeline targets oncology and autoimmune diseases through RNA based CAR approaches designed to improve accessibility, reduce complexity, and enable programmable immune responses for patients.Explore more
Create Medicines's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Create Medicines Org Chart

PhoneEmail
Brett Kaplan, Chief Financial Officer & Chief Business Officer at Create Medicines
United States flag for contact location.

Chief Financial Officer & Chief Business Offi...

PhoneEmail
Jerome Chal, Chief Technology Officer at Create Medicines
United States flag for contact location.

Chief Technology Officer

PhoneEmail
Matthew Maurer, Chief Medical Officer at Create Medicines
United States flag for contact location.

Chief Medical Officer

PhoneEmail
Curtis Demick, Chief People Officer at Create Medicines
United States flag for contact location.

Chief People Officer

Flame icon indicating likelihood to engage via phone.PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MK
United States flag for contact location.

Senior Controller

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Top Business Services Companies

Frequently Asked Questions Regarding Create Medicines

What is Create Medicines's official website?
Create Medicines's official website is www.createmedicines.com
What is Create Medicines's Revenue?
Create Medicines's revenue is $9.7 Million
What is Create Medicines's SIC code?
Create Medicines's SIC: 87,873
What is Create Medicines's NAICS code?
Create Medicines's NAICS: 54,541
How many employees does Create Medicines have?
Create Medicines has 11-50 employees
What industry does Create Medicines belong to?
Create Medicines is in the industry of: Business Services, Research & Development
Who is the CFO of Create Medicines?
Create Medicines's CFO is Brett Kaplan
Who is the CTO of Create Medicines?
Create Medicines's CTO is Jerome Chal
What does Create Medicines do?

CREATE Medicines is a clinical-stage biotechnology company developing in vivo immune programming therapies using its proprietary mRNA-LNP platform. The company focuses on engineering immune cells directly inside the body, including T cells, NK cells, and myeloid cells, to create scalable, repeat-dose, off-the-shelf immunotherapies. Its pipeline tar... gets oncology and autoimmune diseases through RNA based CAR approaches designed to improve accessibility, reduce complexity, and enable programmable immune responses for patients.Read More

What are Create Medicines social media links?
Create Medicines Twitter page
Who invested in Create Medicines?
Create Medicines has 6 investors including Alexandria, Newpath Partners, ARCH Venture Partners and Hatteras Venture Partners.
Is Create Medicines a public company?
Create Medicines is private company therefore does not currently have an official ticker symbol
See more information about Create Medicines

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.